These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7885543)

  • 1. Cranial MRI in PKU: evaluation of a critical threshold for blood phenylalanine.
    Ullrich K; Weglage J; Schuierer G; Fünders B; Pietsch M; Koch HG; Hahn-Ullrich H
    Neuropediatrics; 1994 Oct; 25(5):278-9. PubMed ID: 7885543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progression of cerebral white matter abnormalities in early treated patients with phenylketonuria during adolescence.
    Weglage J; Bick U; Schuierer G; Pietsch M; Sprinz A; Zass R; Ullrich K
    Neuropediatrics; 1997 Aug; 28(4):239-40. PubMed ID: 9309716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain imaging and proton magnetic resonance spectroscopy in patients with phenylketonuria.
    Möller HE; Weglage J; Bick U; Wiedermann D; Feldmann R; Ullrich K
    Pediatrics; 2003 Dec; 112(6 Pt 2):1580-3. PubMed ID: 14654669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Brain white matter lesions of children with phenylketonuria before and after treatment].
    Wang ZX; Zhou ZS; Yu WM
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Feb; 8(1):13-6. PubMed ID: 16522231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood-brain barrier phenylalanine transport and individual vulnerability in phenylketonuria.
    Möller HE; Weglage J; Wiedermann D; Ullrich K
    J Cereb Blood Flow Metab; 1998 Nov; 18(11):1184-91. PubMed ID: 9809507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Did the change of technique of screening investigations influence on improvement of test credibility in recognizing and differentiating diagnostics of hiperphenylalaninemias?].
    Didycz B; Lemańska D; Słuszniak A
    Przegl Lek; 2009; 66(1-2):11-3. PubMed ID: 19485249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI abnormalities in normal-appearing brain tissue of treated adult PKU patients.
    Ding XQ; Fiehler J; Kohlschütter B; Wittkugel O; Grzyska U; Zeumer H; Ullrich K
    J Magn Reson Imaging; 2008 May; 27(5):998-1004. PubMed ID: 18425822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Magnetic resonance imaging of the brain in phenylketonuria].
    Izumi M; Yamazaki H; Nakabayashi H; Owada M
    No To Hattatsu; 2006 Jan; 38(1):27-31. PubMed ID: 16447793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variability of blood-brain ratios of phenylalanine in typical patients with phenylketonuria.
    Rupp A; Kreis R; Zschocke J; Slotboom J; Boesch C; Rating D; Pietz J
    J Cereb Blood Flow Metab; 2001 Mar; 21(3):276-84. PubMed ID: 11295882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended tetrahydrobiopterin loading test in the diagnosis of cofactor-responsive phenylketonuria: a pilot study.
    Fiege B; Bonafé L; Ballhausen D; Baumgartner M; Thöny B; Meili D; Fiori L; Giovannini M; Blau N
    Mol Genet Metab; 2005 Dec; 86 Suppl 1():S91-5. PubMed ID: 16290003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance imaging of the brain in phenylketonuria.
    Cleary MA; Walter JH; Wraith JE; Jenkins JP; Alani SM; Tyler K; Whittle D
    Lancet; 1994 Jul; 344(8915):87-90. PubMed ID: 7912392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unexpected white matter changes in an early treated PKU case and improvement after dietary treatment.
    Battistini S; De Stefano N; Parlanti S; Federico A
    Funct Neurol; 1991; 6(2):177-80. PubMed ID: 1916459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance imaging of the brain in adolescents with phenylketonuria and in one case of 6-pyruvoyl tetrahydropteridine synthase deficiency.
    Pietz J; Meyding-Lamadé UK; Schmidt H
    Eur J Pediatr; 1996 Jul; 155 Suppl 1():S69-73. PubMed ID: 8828614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The outcome of white matter abnormalities in early treated phenylketonuric patients: A retrospective longitudinal long-term study.
    Mastrangelo M; Chiarotti F; Berillo L; Caputi C; Carducci C; Di Biasi C; Manti F; Nardecchia F; Leuzzi V
    Mol Genet Metab; 2015 Nov; 116(3):171-7. PubMed ID: 26283467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Near-microscopic magnetic resonance imaging of the brains of phenylalanine hydroxylase-deficient mice, normal littermates, and of normal BALB/c mice at 9.4 Tesla.
    Kornguth S; Anderson M; Markley JL; Shedlovsky A
    Neuroimage; 1994 Jun; 1(3):220-9. PubMed ID: 9343573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of computerized neuropsychological tests and of nuclear magnetic resonance spectroscopy in clinical assessment of adult patients with phenylketonuria].
    Bik-Multanowski M; Pietrzyk JJ
    Przegl Lek; 2011; 68(3):127-31. PubMed ID: 21812225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of tetrahydrobiopterin (BH4) responsiveness in phenylketonuria.
    Fiege B; Blau N
    J Pediatr; 2007 Jun; 150(6):627-30. PubMed ID: 17517248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Future role of large neutral amino acids in transport of phenylalanine into the brain.
    Matalon R; Surendran S; Matalon KM; Tyring S; Quast M; Jinga W; Ezell E; Szucs S
    Pediatrics; 2003 Dec; 112(6 Pt 2):1570-4. PubMed ID: 14654667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Differential diagnosis and therapy of various forms of hyperphenylalaninemia: facts and fiction].
    Endres W
    Wien Klin Wochenschr; 1992; 104(16):503-9. PubMed ID: 1413808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vivo NMR spectroscopy in patients with phenylketonuria: changes of cerebral phenylalanine levels under dietary treatment.
    Möller HE; Vermathen P; Ullrich K; Weglage J; Koch HG; Peters PE
    Neuropediatrics; 1995 Aug; 26(4):199-202. PubMed ID: 8544958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.